According to the deputy, “all these cases of acute renal failure in children are associated with the use of the contaminated medical product from Maiden Pharmaceuticals.”
An investigation into the incident began in October. The president of the African country, Adama Barrow, promised that the investigation will be carried out in the most exhaustive way. He also ordered the suspension of the licenses of pharmacies that sold cough syrup, as well as an importing company.
On October 5, the WHO issued a global warning about the dangers of four types of cough syrup for children – these are promethazine oral solutions: cough syrups for children Kofexmalin (“Kofeksmalin”) and Makoff (“Makoff “), as well as cold syrup Magrip N (“Magrip-N”). All of them are produced by the Indian pharmaceutical company Maiden Pharmaceuticals Limited.
The Government of India recently informed the WHO that tests of syrup samples from the consignments that were sent to The Gambia showed that the product meets the government requirements for its parameters. Meanwhile, the Gambian Parliament urged the Gambian government to file a proper lawsuit against the Indian company.